MDSCs might be "Achilles heel" for eradicating CSCs

Cytokine Growth Factor Rev. 2022 Jun:65:39-50. doi: 10.1016/j.cytogfr.2022.04.006. Epub 2022 May 4.

Abstract

During tumor initiation and progression, the complicated role of immune cells in the tumor immune microenvironment remains a concern. Myeloid-derived suppressor cells (MDSCs) are a group of immune cells that originate from the bone marrow and have immunosuppressive potency in various diseases, including cancer. In recent years, the key role of cancer stemness has received increasing attention in cancer development and therapy. Several studies have demonstrated the important regulatory relationship between MDSCs and cancer stem cells (CSCs). However, there is still no clear understanding regarding the complex interacting regulation of tumor malignancy, and current research progress is limited. In this review, we summarize the complicated role of MDSCs in the modulation of cancer stemness, evaluate the mechanism of the relationship between CSCs and MDSCs, and discuss potential strategies for eradicating CSCs with respect to MDSCs.

Keywords: Cancer plasticity; Cancer stem cells; Cytokines; MDSCs; Tumor progression.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Myeloid-Derived Suppressor Cells*
  • Neoplasms*
  • Neoplastic Stem Cells
  • Tumor Microenvironment